联系客服

002082 深市 万邦德


首页 公告 万邦德:2020年第三季度报告全文(更新后)

万邦德:2020年第三季度报告全文(更新后)

公告日期:2020-11-02

万邦德:2020年第三季度报告全文(更新后) PDF查看PDF原文

          万邦德医药控股集团股份有限公司

                    2020 年第三季度报告

                        2020 年 10 月


                      第一节 重要提示

    公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。

    所有董事均已出席了审议本次季报的董事会会议。

    公司负责人赵守明、主管会计工作负责人赵军辉及会计机构负责人(会计主管人员)韩彬声明:保证季度报告中财务报表的真实、准确、完整。


                    第二节 公司基本情况

一、主要会计数据和财务指标
公司是否需追溯调整或重述以前年度会计数据
√ 是 □ 否
追溯调整或重述原因
同一控制下企业合并

                                                                上年度末                本报告期末比上年
                                  本报告期末                                                度末增减

                                                      调整前            调整后            调整后

 总资产(元)                    5,113,578,472.93    3,800,535,719.63    5,109,471,140.05            0.08%

 归属于上市公司股东的净资产

 (元)                          2,437,007,526.57    1,638,323,644.36    2,537,656,949.99            -3.97%

                                                            本报告                                年初至
                                                            期比上                                报告期
                              本报告      上年同期                年初至      上年同期      末比上
                                                            年同期  报告期                      年同期
                                期                          增减      末

                                                                                                  增减

                                        调整前  调整后  调整后            调整前  调整后  调整后

                                                                    11,210,3  11,947,2  12,469,7

 营业收入(元)              4,514,62  4,088,80  4,252,54

                                                            6.16%  11,704.1  47,197.4  33,686.6  -10.10%
                              7,027.65  5,159.84  8,507.40

                                                                          1        8        2

 归属于上市公司股东的净利润  206,584.  22,395,6  53,828,3            120,781,  75,300,2  184,912,

 (元)                                                    -99.62%                              -34.68%
                                  82    34.16    41.47            262.69    61.18  860.72

 归属于上市公司股东的扣除非    -17,899,  21,600,7  53,033,4  -133.75  96,489,8  71,672,7  181,285,

 经常性损益的净利润(元)                                                                        -46.77%
                                942.80    21.54    28.85      %    76.27    19.39  318.93

 经营活动产生的现金流量净额    -72,337,  -388,861  -331,189            -232,739  -319,115  -145,24

 (元)                                                    -78.16%                                60.24%
                                902.38  ,453.50  ,346.88            ,111.66  ,427.95  2,699.59

 基本每股收益(元/股)          0.0003      0.09    0.0871  -99.66%      0.20      0.32    0.30  -33.33%

 稀释每股收益(元/股)          0.0003      0.09    0.0871  -99.66%      0.20      0.32    0.30  -33.33%

 加权平均净资产收益率          0.01%    1.49%    2.29%  -2.28%    4.77%    4.92%    8.11%  -3.34%

非经常性损益项目和金额
√ 适用 □ 不适用

                                                                                                  单位:元

                        项目                          年初至报告期期末金额              说明

 非流动资产处置损益(包括已计提资产减值准备的冲销部                -237,314.97

 分)
 计入当期损益的政府补助(与企业业务密切相关,按照国家

 统一标准定额或定量享受的政府补助除外)                          15,642,882.67

 非货币性资产交换损益                                            12,657,800.00

 除上述各项之外的其他营业外收入和支出                            2,407,890.64

 减:所得税影响额                                                5,704,524.02

    少数股东权益影响额(税后)                                    475,347.90

 合计                                                            24,291,386.42              --

对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目,以及把《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目,应说明原因
□ 适用 √ 不适用
公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义、列举的非经常性损益项目界定为经常性损益的项目的情形。
二、报告期末股东总数及前十名股东持股情况表
1、普通股股东和表决权恢复的优先股股东总数及前 10 名股东持股情况表

                                                                                                  单位:股

 报告期末普通股股东总数                              报告期末表决权恢复的优先

                                              26,066  股股东总数(如有)                              0

                                          前 10 名股东持股情况

                                                              持有有限售条        质押或冻结情况

  股东名称      股东性质      持股比例      持股数量    件的股份数量

                                                                              股份状态        数量

 万邦德集团有  境内非国有法                                                质押

 限公司        人                  31.46%    194,466,282    149,522,922                    153,150,000

 赵守明        境内自然人            6.90%      42,646,878      42,646,878  质押              42,640,000

 嘉兴嘉昊九鼎  境内非国有法

 投资中心(有  人                    5.24%      32,368,573      32,368,573

 限合伙)

 庄惠          境内自然人            4.60%      28,431,251      28,431,251  
[点击查看PDF原文]